Check out India Today’s coverage of a One Health Trust co-authored study. The study projects that without proper investments in public health infrastructure—including clean water, sanitation, and vaccination— and other measures, global antibiotic consumption could rise by over 50 percent by 2030, reaching 75.1 billion daily doses. Read the coverage here: https://lnkd.in/dQE-VfR9 Check out the article discussed, out in PNAS here: https://lnkd.in/dG2CPKzp #AMR #GlobalHealth #AntibioticResistance
One Health Trust
研究服务
Washington,DC 22,558 位关注者
Actionable research to improve health and well-being worldwide
关于我们
We live in an interconnected world: the health and well-being of the environment, animals, and humans are intertwined in ways that are becoming increasingly apparent. Tackling today’s greatest challenges—whether climate change, pandemics, or drug resistance—requires an approach that recognizes these relationships. The One Health Trust (OHT), which was founded as the Center for Disease Dynamics, Economics & Policy (CDDEP) in 2010, uses research and stakeholder engagement to improve the health and well-being of our planet and its inhabitants. For more than a decade, OHT researchers have conducted vitally important work on major global health challenges, including Covid-19, antimicrobial resistance, hospital infections, tuberculosis, malaria, pandemic preparedness and response, vaccines, medical oxygen shortages, and noncommunicable diseases. OHT’s mandate includes issues related to climate change, biodiversity protection, and the effect of changing human diets on the planet. At OHT, we believe that answers to the world’s most critical questions lie between disciplines. Accordingly, our researchers employ a range of expertise—from economics, epidemiology, disease modeling, and risk analysis to clinical and veterinary medicine, geographic information systems, and statistics—to conduct actionable, policy-oriented research. OHT has offices in Washington, D.C.and Bangalore, India, with researchers based in North America, Africa, and Asia. Our projects lead to policy recommendations and scientific studies published in leading journals. We are experienced in addressing country-specific and regional issues as well as global challenges. Our research is renowned for innovative approaches to design and analysis, and we communicate our work to diverse stakeholders.
- 网站
-
https://www.onehealthtrust.org
One Health Trust的外部链接
- 所属行业
- 研究服务
- 规模
- 11-50 人
- 总部
- Washington,DC
- 类型
- 非营利机构
- 创立
- 2010
- 领域
- Public Health、Economics、Public Policy、Global Health、Antimicrobial Resistance、Environmental Health、Vaccines、Malaria、Communicable Diseases、COVID-19、Health Communications、One Health、Zoonotic Diseases、Noncommunicable Diseases、Gender Equity、Health in India、Antimicrobial Stewardship、health economics、podcast和infographics
地点
One Health Trust员工
-
Ramanan Laxminarayan
One World - One Health
-
Amit Summan
Economist | Postdoctoral Research Fellow at OHT
-
Prashant Arukia
Co-Founder & CEO- Public Health Technologies Trust | One Health Trust | Digital Health, Innovation of 5 Healthcare solutions | Impacted 2+ million…
-
Erta Kalanxhi
Director of Partnerships | Global Health Advocacy | Antimicrobial Resistance
动态
-
Zoonotic diseases, also known as zoonoses, are infections that can spread from animals to humans and vice versa. With new cases of H5N1 avian influenza in humans and the rapid spread of mpox in several countries in Africa, it is important we work to understand and control the growing threat of zoonoses. Find out facts about zoonotic disease and how disease spillover happens! Check out our infographic here: https://lnkd.in/d3xGEy2k Learn a bit about what has happened with avian influenza this year in our podcast with Dr. Richard Webby, Director of the World Health Organization Collaborating Centre for Studies on the Ecology of Influenza in Animals and Birds at St. Jude Children's Research Hospital: https://lnkd.in/d3Py7JcP #OneHealth #ZoonoticDiseases #GlobalHealth
-
+1
-
?? Tackling Antimicrobial Resistance (AMR) through Vaccines in Kenya ?????? On October 30-31, 2024, experts from KEMRI, the One Health Trust (OHT), gathered in Nairobi for an impactful two-day Global Antibiotic Resistance Partnership (GARP) workshop. The focus? The crucial role vaccines play in mitigating the growing threat of AMR in Kenya. ?? The workshop brought together key stakeholders—healthcare professionals, researchers, and policymakers—to explore how vaccines can reduce the burden of AMR and strengthen the path toward universal health coverage and the UN’s Sustainable Development Goals. ???? Key highlights from the workshop: ?? Evidence-based solutions for AMR through vaccines. ?? Panel discussions on Kenya’s unique AMR challenges and vaccine strategies. ?? Drafting policy recommendations to include vaccines in national AMR frameworks. Speakers addressed the need to overcome barriers like vaccine hesitancy and highlighted the importance of community engagement to build trust. Experts shared invaluable insights on the role of vaccines in reducing disease burden and combating AMR. Key recommendations include: Expanding vaccine coverage to include adults and vulnerable populations. Increasing vaccine accessibility and distribution, especially in remote areas. Engaging public-private partnerships for sustainable vaccination efforts. ?? Learn more about the workshop's findings and the urgent need to incorporate vaccines into AMR strategies in our latest blog post! https://lnkd.in/eEdXge4u #AMR #Vaccines #OneHealth #Kenya #PublicHealth #GARP #VaccinationForHealth #AntimicrobialResistance #KenyaHealth #AMRSolutions #HealthPolicy Robert S. Onsare Felix Bahati Erta Kalanxhi -Sam Kariuki -Drugs for Neglected Diseases initiative - DNDi Kenya Medical Research Institute (KEMRI) Kenyatta University Anthony Sifuna Masinde Muliro University of Science and Technology Jomo Kenyatta University of Agriculture and Technology (JKUAT) Emmanuel Elebesunu Ministry of Health, Kenya Simon M. Kiambati
Insights from the 2024 Meeting of the Global Antimicrobial Resistance Partnership (GARP) in Kenya - One Health Trust
https://onehealthtrust.org
-
Last week, for World Antimicrobial Resistance Awareness Week (#WAAW), OHT hosted a webinar exploring ways to include vaccines in AMR control strategies. Our experts discussed the progress and barriers to including vaccines in AMR strategies; the importance of adult vaccination programs, and the World Health Organization’s People-Centered approach to AMR. Missed it? Watch the recording here: https://lnkd.in/dEeW_2rE #VaccinesWork #GlobalHealth #AMR
A Shot at Prevention – Bringing vaccines into AMR control - One Health Trust
https://onehealthtrust.org
-
The Innovation News Network’s coverage of the One Health Trust collaborative study on global antibiotic use since 2016 notes that the study highlights fluctuating but significant increases in usage. To control antimicrobial resistance, there is an urgent need for action to reduce antibiotic misuse in high-income countries and to invest in healthcare and water and sanitation infrastructure in low- and middle-income countries. Read the coverage here: https://lnkd.in/eYyaRn-T Find the study in PNAS here: https://lnkd.in/dG2CPKzp #AMR #AntibioticUse #COVID19
-
A new One Health Trust study out in BMJ Global Health shows that the COVID-19 pandemic had a notable impact on alcohol and tobacco use in India, with consumption decreasing during the pandemic. Using data from the National Family Health Survey (2019-2021) OHT's Dr. Amit Summan and Dr. Ramanan Laxminarayan found that tobacco use dropped by 1.4%, and alcohol use by 0.3% among individuals surveyed after the pandemic lockdown. The decline was more significant in low-wealth, rural areas, and among males and older adults. Smokeless tobacco, cigarettes, and bidis (hand-rolled tobacco cigarettes) saw a reduction, along with a 4.6% drop in secondhand smoke exposure. These findings highlight the potential for targeted policies to support cessation and curb consumption. Read it here: https://lnkd.in/dRut_zNG #COVID19 #PublicHealth #TobaccoUse #AlcoholUse #India
Changes in tobacco and alcohol consumption during the COVID-19 pandemic in India: a propensity score matching approach
gh.bmj.com
-
What might be expect from the new Trump administration when it comes to global health? And how should we, as the global health community, engage? It would be safe to assume that the new administration will do things differently. They may question the current trajectory of global health spending, whether it offers greatest value and how it meets US national strategic interests. They may also be open to new ideas and opportunities that are aligned with their mandate for a US-first approach. Nature Magazine asked a few of us what we might ask of the new administration, and our responses are below. My very specific ask was for the establishment of a Global Antibiotic Access Facility that would promote and finance appropriate access to effective antibiotics worldwide, which would save lives, encourage diagnostics- and surveillance-guided use of antibiotics, and encourage investment into new antibiotics by providing markets to biotechs in this space, many of which are based in the US. This could all be done for less than billion dollars a year. Let us remember that some of the greatest institutions were established under Presidents who were not very popular with the environmental/health worlds. The US Environmental Protection Agency was set up under Nixon. PEPFAR happened under and because of George W. Bush. And Covid vaccines were developed in record time with Operation Warpspeed under Trump. It is entirely possible that this new administration, for all its expected challenges, will leave behind a positive legacy that will advance global health. Whatever the global health and climate conversation may be about, it would be a mistake for us to sit on the sidelines. One Health Trust
Hopes, fears and uncertainty: life scientists react to Trump’s election victory
nature.com
-
2024 has been a huge year for Dengue outbreaks. A warming world due to climate change and increasing urbanization have exacerbated its spread, allowing the mosquitoes that transmit the virus to thrive. The deadly disease, with no specific treatment, was rampant this year in Brazil, Sri Lanka, India, Thailand, and many other countries and regions. During Brazil's outbreak this year, we spoke to Dr. Andre Siqueira, now head of the Dengue program in Brazil for Drugs for Neglected Diseases initiative - DNDi, about why dengue outbreaks are worsening and what's being done to stop them. Listen here: https://lnkd.in/dbqHnenG Watch the DNDi documentary on the global dengue problem and what is being done to address it here: https://lnkd.in/gNj9chPS #DengueAwareness #MosquitoControl #GlobalHealth #TropicalDiseases #VectorBorneDiseases #ClimateChange
Treating a feverish planet: The Dengue Alliance
https://www.youtube.com/
-
In ET Edge Insights’ coverage of the One Health Trust collaborative study on global antibiotic consumption, OHT's Dr. Eili Klein highlights the need to focus on reducing inappropriate antibiotic use in high-income countries and the importance of substantial investments in healthcare infrastructure in low- and middle-income countries to effectively curb disease transmission. Read the coverage here: https://lnkd.in/d92pJbhu Find the study in PNAS here: https://lnkd.in/dG2CPKzp
Antibiotic resistance looms large as global consumption surges: Report - ET Edge Insights
https://etedge-insights.com
-
For World AMR Awareness Week #WAAW, read our blog on key takeaways from the week of the #UNGA High-level Meeting on #AMR https://lnkd.in/dFMwKqfA Watch the recorded live stream of our UNGA side event on AMR: https://lnkd.in/d7iMJzM2
Sustainable access to effective antibiotics: From UNGA to Impact
https://www.youtube.com/